Research Papers:

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma

Wei Wang, Wei-Dong Jia, Bing Hu and Yue-Yin Pan _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:26434-26447. https://doi.org/10.18632/oncotarget.15507

Metrics: PDF 2925 views  |   HTML 2675 views  |   ?  


Wei Wang1,*, Wei-Dong Jia2, Bing Hu1, Yue-Yin Pan1,*

1Department of Medical Oncology, Anhui Provincial Hospital, Anhui Medical University, Hefei 230001, PR China

2Department of Hepatic Surgery, Anhui Provincial Hospital, Anhui Medical University, Hefei 230001, PR China

*These authors contributed equally to this work

Correspondence to:

Wei Wang, email: [email protected]

Yue-Yin Pan, email: [email protected]

Keywords: RAB10, hepatocellular carcinoma, oncogene, biomarker, therapeutic target

Received: December 08, 2016     Accepted: February 07, 2017     Published: February 19, 2017


Hepatocellular carcinoma (HCC), one of the most common and lethal cancers worldwide, has a high recurrence rate with current treatment modalities. Identifying biomarkers for early diagnosis and discovering new sufficient molecular targets for the development of targeted therapies are urgently needed. RAB10, a member of the RAS family, has been shown to be highly expressed in HCC. However, the function of RAB10 in HCC is less studied. Here we report that RAB10 acts as an oncogene in HCC. The shRNA-mediated knockdown of RAB10 significantly reduced the proliferation of HCC cells and colony formation, induced cell cycle arrest at G0/G1 phase and increased apoptosis in vitro. In addition, RAB10 knockdown suppressed HCC growth in nude mice. Moreover, RAB10 silencing decreased the phosphorylation of InsR, Met/HGFR, Ron/MST1R, Ret, c-Kit/SCFR, EphA3, EphB4, Tyro3/Dtk, Axl, Tie2/TEK, VEGFR2/KDR, Akt/PKB/Rac, S6 Ribosomal Protein and c-Abl, while the phosphorylation of HSP27, p38 MAPK, Chk2 and TAK1 increased significantly. These results suggest that RAB10 regulates cell survival and proliferation through multiple oncogenic, cell stress and apoptosis pathways. More importantly, high RAB10 expression levels in HCC cells correlated with a poor prognosis in HCC patients. Therefore, our findings revealed an oncogenic role for RAB10 in the pathogenesis of HCC and that RAB10 is a potential molecular target or a biomarker for HCC.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15507